SB 1399 requires health plans with fixed-fee contracts (prepaid capitated contracts) with Arizona's healthcare administration to submit annual reports by December 1. These reports must detail the percentage of contract funds spent on direct patient care versus administrative costs, broken down by specific categories. The reports are submitted to the joint legislative budget committee, governor, and relevant health committees. This bill mandates transparency about how funds are allocated, directly affecting health plans operating under these contracts. It does not change funding levels or healthcare services, only requiring standardized financial reporting.
HB 2660 amends Arizona's chiropractic licensure laws to expand the grounds for disciplinary action against chiropractors. It adds specific prohibitions, including deceptive advertising (e.g., advertising "free" services without disclosing what's included), billing for unprovided services, and soliciting vulnerable patients (like accident victims within 15 days) without proper consent. The bill also strengthens the board's investigation powers, allowing it to require medical/mental exams during probes and issue emergency license suspensions if public safety is at immediate risk. These changes directly affect licensed chiropractors in Arizona by increasing accountability for conduct impacting patient safety and transparency in billing and advertising.
SB 1124 requires Arizona state health profession regulatory boards to provide health professionals with a 14-day written notice before voting to mandate a psychological, psychiatric, or physical evaluation. The notice must summarize the complaint or action prompting the evaluation, and the health professional can submit written responses or request a hearing to present their case. If the board proceeds with the evaluation and later takes no disciplinary or non-disciplinary action, the board must reimburse the health professional for the evaluation costs. This bill directly affects health professionals facing potential evaluation requirements and ensures procedural fairness before such actions are taken.
SB 1214 restricts Arizona physicians from using stem cells or birth tissue derived from aborted fetuses or embryos for therapy. It allows non-FDA-approved stem cell or birth tissue therapies only for orthopedics, wound care, or pain management, provided the cells come from FDA-registered or certified facilities (like blood banks or tissue banks) and meet specific safety and viability standards. The bill requires physicians to disclose in advertising and obtain detailed informed consent stating the therapy isn't FDA-approved, and mandates facilities to provide full certification details to physicians. These provisions directly affect medical providers, clinics, and tissue suppliers offering such therapies in Arizona.
SB 1212 prohibits Arizona health insurance companies from reimbursing health care providers at different rates based on a patient's vaccination status. Effective January 1, 2027, the law applies to all health insurance plans sold in Arizona and directly affects insurers, health care providers (like doctors and clinics), and patients covered by those plans. It requires that reimbursement rates remain uniform regardless of whether a patient has received vaccines, eliminating differential payments tied to vaccination status. The bill changes existing reimbursement practices by mandating equal payment for covered services, irrespective of a patient's immunization history.
SB 1345 restricts Arizona health agencies from accepting or investigating anonymous complaints against healthcare facilities, requiring complaints to come directly from the person affected by the issue or from a witness to the alleged conduct. This bill directly affects the Arizona Department of Health Services and the Arizona Health Care Cost Containment System, which handle facility complaints. The key provision prohibits anonymous complaints unless they originate from the subject of the allegation or a witness, eliminating the ability to file anonymous reports. The bill does not change healthcare standards or funding but alters the complaint process for state oversight agencies.
SB 1476 modifies Arizona law to address child neglect cases involving prenatal substance exposure. It creates an affirmative defense for mothers who completed alcohol or drug treatment during pregnancy, preventing them from being charged with child neglect for that specific conduct. The bill specifies that child neglect related to untreated prenatal substance use remains a class 6 felony, but the defense applies if treatment was completed. This directly affects mothers facing neglect charges due to substance use during pregnancy who have accessed treatment services. The policy change shifts legal consequences for a defined subset of cases without altering general neglect definitions.
SB 1011 requires medical examiners in Arizona to conduct autopsies for sudden, unexplained infant deaths and follow specific protocols. It mandates reviewing the infant’s immunization history and recent medical treatments, then reporting all such cases to a national registry aligned with CDC guidelines. The bill directly affects infants experiencing unexplained deaths, their families, and county medical examiners who must implement these procedures. If passed, it would standardize investigations for these cases but does not change prevention or treatment policies. (Note: This is a proposed bill, as it is currently prefiling with no enacted status.)
This bill establishes rules for overdose and disease prevention programs in Arizona, allowing cities, counties, and local health departments to operate services that provide free needles, naloxone for overdose reversal, and referrals to treatment. The legislation requires these programs to offer educational materials on preventing infections and injuries while mandating that the number of needles disposed of equals the number distributed to ensure safety. Additionally, the bill creates a new fund to support rural health initiatives, requiring the state to hold public meetings in major metropolitan areas to gather community input before spending the allocated money. Finally, it explicitly prohibits the use of opioid settlement funds to finance safer smoking equipment, clarifying that such funds cannot be used for tools designed to reduce health risks associated with inhaling drugs.
SB 1118 appropriates state funds for a grant program to help rural hospitals cover costs of radiation protection systems. The bill directly affects rural hospitals (defined as those in counties with under 1 million residents) by providing financial assistance for shielding systems that protect staff during medical procedures using radiation. Key provisions require these systems to meet specific standards: equivalent protection to a .25mm lead apron and include real-time dosimetry to measure radiation exposure. The grant program is administered by the Arizona Department of Health Services for fiscal year 2026-2027.